Alexander Robert Ingram
Affiliations
- Director at Biocryst Pharmaceuticals Inc (BCRX), 2023-03-02
- at Black Diamond Therapeutics Inc. (BDTX), 2022-12-20
- Director at Novan Inc. (NOVN), 2020-07-31
- Large Shareholder at Phasebio Pharmaceuticals Inc (PHAS), 2018-10-24
- Director at Cree Inc (CREE), 2018-10-18
- Large Shareholder at G1 Therapeutics Inc. (GTHX), 2018-06-01
- Director at Valeant Pharmaceuticals International Inc. (VRX), 2017-04-04
- Large Shareholder, Other at Clearside Biomedical Inc. (CLSD), 2017-01-20
- Director at Regeneron Pharmaceuticals Inc (REGN), 2015-05-27
- Director at Edwards Lifesciences Corp (EW), 2015-05-19
- Director at Allergan Inc (AGN), 2012-10-31
- Director at Pharmaceutical Product Development Inc (PPDI), 2011-12-06
- Director at Lowes Companies Inc (LOW), 2011-04-04
- Director at Valeant Pharmaceuticals International (VRX), 2010-10-01
- Director at Osi Pharmaceuticals Inc (OSIP), 2010-06-09
- Director at Wachovia Corp New (WB), 2009-01-02
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| BDTX | $30.46 | 5,000 | Director | 5,000 | 2020-09-30 | Filing | |
| BCRX | $1.45 | 20,000 | Director | 48,088 | 2019-11-18 | Filing | |
| NOVN | $2.21 | 50,000 | Director | 169,777 | 2019-05-22 | Filing | |
| NOVN | $2.84 | 50,000 | Director | 119,777 | 2018-09-28 | Filing | |
| NOVN | $4.70 | 8,465 | Director | 69,777 | 2017-08-29 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| CREE | $27.67 | 3,750 | Director | 48,846 | 2015-12-01 | Filing | |
| REGN | $513.39 | 1,379 | Director | 1,500 | 2015-05-27 | Filing | |
| EW | $90.26 | 12,500 | Director | 30,541 | 2014-07-31 | Filing | |
| EW | $87.72 | 15,000 | Director | 36,856 | 2012-05-25 | Filing | |
| EW | $87.79 | 10,000 | Director | 46,302 | 2011-05-09 | Filing |